Results 151 to 160 of about 29,341 (237)

Hope on the horizon: FDA approves eplontersen for hereditary transthyretin-mediated amyloidosis

Insa Binte Anwar, Iqra Furqan Ahmed, Farrouq Mahmood, Abdul Haseeb, Khabab Abbasher Hussien Mohamed Ahmed   +4 more
openalex   +1 more source

A Comprehensive Review of the Management of Light-Chain (AL) and Transthyretin (ATTR) Cardiac Amyloidosis. [PDF]

Rev Cardiovasc Med
Alkhatib A, Alashqar R, Abdallah AW, Abu-Nejim H, Hammad A, Khraisat O, Abuzaid AS.   +6 more
europepmc   +1 more source

Testing the utility of the first step of system evaluation theory in creating a system map of care for cardiac amyloidosis early detection: A case study. [PDF]

PLoS One
Ball SL, Koskan A, Guzman J, Dev S.
europepmc   +1 more source

Atrial Fibrillation/Flutter in Transthyretin Cardiac Amyloidosis: Prevalence, Incidence, Clinical Predictors, and Effect of Tafamidis. [PDF]

JACC Adv
Chan N, Brailovsky Y, Teruya S, Mirabal A, Weinsaft AY, De Los Santos J, Guadalupe S, Jimenez M, Helmke S, Cuomo M, Smiley D, Biviano A, Dizon J, Wan E, Yarmohammadi H, Maurer MS.   +15 more
europepmc   +1 more source

Monitoring Disease Progression in Transthyretin Amyloid Cardiomyopathy

Adam Ioannou
openalex   +1 more source

Disparities in diagnosis and outcomes in American patients with transthyretin cardiac amyloidosis [PDF]

Joyce Ngouchet Nouhossi, Iva Minga, Teodora Szasz, Vien T. Truong, Amber E. Johnson, Edward Yang, Srisha Kotlo, Varun Subashchandran, Frank Medina, Karolina M. Zaręba, Akash Goyal, Orlando P. Simonetti, Amit R. Patel, Cristiane Carvalho Singulane, Jai Singh, Vidya Nadig, Shaimaa Fadl, Cory R. Trankle, Nitasha Sarswat, Hena Patel, Victor Mor‐Avi, B. Smith, Jeremy Slivnick   +22 more
openalex   +1 more source

Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial. [PDF]

Circulation
Fontana M, García-Pavía P, Grogan M, Shah SJ, Engelmann MDM, Hovingh GK, Kristen AV, Lim-Watson MZ, Malling B, Kar S, Revanna M, Sarswat N, Tsujita K, Alexander KM, Maurer MS.   +14 more
europepmc   +1 more source

Global Longitudinal Strain for Prognostic Staging in Wild-Type Transthyretin Cardiac Amyloidosis. [PDF]

Circ Cardiovasc Imaging
Debonnaire P, L'Hoyes W, Donal E, Verheyen N, Vervloet D, Dujardin K, Pouleur AC, Dulgheru R, Sarli Issa V, Droogmans S, Jurcut R, Regeer M, Dupont M, Bondue A, Timmermans P, Bohyn A, Christiaen E, Wyseure N, Bezard M, Zach D, Schwegel N, Knapen R, Buytaert L, de Marneffe N, Adam R, Ajmone Marsan N, Tavernier R, Buysschaert I, Trenson S.   +28 more
europepmc   +1 more source

Efficacy of Contractility Modulation Therapy in Patients with Transthyretin Amyloid Cardiomyopathy, Mildly Reduced to Reduced EF and NYHA III and IV: A Multicentric, Prospective Pilot Study for AMY-CCM Registry

Procolo Marchese, Francesca Gennaro, Giovanni Mazzotta, Pierfrancesco Grossi, L Cocchiara, Stefano Guarracini, L Mazzocchetti, Matteo Ziacchi, Mauro Biffi, R Magnano, Massimo Di Marco, Matteo Ruzzolini, Antonio Bisignani, Matteo Bianco, Paolo Garrone, Walter Grosso Marra, Margherita Cannillo, Carlo Lavalle, Daniele Masarone, Cristina Chimenti   +19 more
openalex   +1 more source

Transthyretin Amyloidosis

Journal of the American College of Cardiology, 2016
openaire   +1 more source